Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BTI Biotechnology Institute is a leading Spanish multinational company specializing in regenerative medicine and oral implantology. Founded in 1999 by Dr. Eduardo Anitua, the company is a global pioneer in the development of Plasma Rich in Growth Factors (PRGF-Endoret) technology, which utilizes a patient's own proteins to accelerate tissue repair and regeneration. BTI operates through two primary divisions: Regenerative Medicine, which applies PRGF technology across dentistry, traumatology, dermatology, and ophthalmology; and Oral Implantology, which manufactures advanced dental implants and prosthetic solutions. The company is highly research-driven, holding over 50 patents and maintaining extensive collaborations with international universities to advance clinical applications of autologous therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BTI Tech.